Abstract
Recent published data have given information on the treatment of anaphylaxis: dosage and pharmacokinetics data on adrenaline autoinjectors, availability of a 100μg adrenaline autoinjector, lack of evidence of the effectiveness of oral corticosteroids in anaphylaxis, management of perioperative allergic reactions, use of biologicals as preventive or adjunctive treatment of anaphylaxis. In France, recent data concern the update of the emergency action plan for allergic reactions and individual healthcare plan for allergic children at school since April 2021, and provision of spare adrenaline autoinjectors in all high schools since 2019. This article aims at reviewing the most recent data on anaphylaxis treatment.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
